Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas

Cancer Letters

Volumn 157, Issue 2, 2000, Pages 145-153

  Mo, Huanbiao ^a   Tatman, Dana ^a   Jung, Manfred ^b   Elson, Charles E ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c NONE

Author keywords

Apoptosis; B16 melanomas; Diet; Farnesol; G1 arrest; Isoprenoids

Indexed keywords

ALCOHOL DERIVATIVE; ANTHRANILIC ACID DERIVATIVE; ESTER DERIVATIVE; FARNESYL ANTHRANILATE; GAMMA TOCOPHEROL; GERANIOL ESTER; ISOPRENOID; MYRCENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL POPULATION; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG POTENCY; FEMALE; IC 50; MELANOMA B16; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; ANTHRANILIC ACIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FARNESOL; MELANOMA, EXPERIMENTAL; MICE; TERPENES; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0034285130     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00490-0     Document Type: Article

References (45)

1. Gibbs J.B., Oliff A. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Ann. Rev. Pharmacol. Toxicol. 37:1997;143-166.
2. Whyte D.B., Kirschmeier P., Hockenberry T.N., Nunez O.I., James L., Catino J.J., Bishop W.R., Pai J.K. K- and N-ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. Biol. Chem. 272:1997;14459-14464.
3. Thibault A., Samid D., Tompkins A.C., Figg W.D., Cooper M.R., Hohl R.J., Trepel J., Liang B., Patronas N., Venzon D.J., Reed E., Myers C.E. Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin. Cancer Res. 2:1996;483-491.
4. Zhang F.L., Casey P.J. Protein prenylation: molecular mechanisms and functional consequences. Ann. Rev. Biochem. 65:1996;241-269.
5. Hjertman M., Wejde J., Dricu A., Carlberg M., Griffiths W.J., Sjovall J., Larsson O. Evidence for protein dolichylation. FEBS Lett. 416:1997;235-238.
6. Dricu A., Wang M., Hjertman M., Malec M., Blegen H., Wejde J., Carlberg M., Larsson O. Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc. Glycobiology. 7:1997;625-633.
7. Sinenski M., Logel J.S. Defective macromolecule biosynthesis and cell cycle progression in a mammalian cell starved for mevalonate. Proc. Natl. Acad. Sci. USA. 82:1985;3257-3261.
8. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature (London). 343:1990;425-430.
9. Correll C.C., Ng L., Edwards P.A. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 269:1994;17390-17393.
10. Meigs T.E., Roseman D.S., Simoni R.D. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the non-sterol mevalonate metabolite farnesol in vivo. J. Biol. Chem. 271:1996;7916-7922.
11. Meigs T.E., Simoni R.D. Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase. Arch. Biochem. Biophys. 345:1997;1-9.
12. Case G.L., He L., Mo H., Elson C.E. Induction of geranyl-pyrophosphate pyrophosphatase activity by cholesterol-suppressive isoprenoids. Lipids. 30:1995;357-359.
13. Fitch M.E., Mangels A.R., Altmann W.A., El Hawry M., Qureshi A.A., Elson C.E. Microbiological screening of mevalonate-suppressive minor plant constituents. J. Agric. Food Chem. 37:1989;687-691.
14. Bostedor R.G., Karkas J.D., Arison B.H., Bansal V.S., Vaidya S., Germershausen J.I., Kurtz M.M., Bergstrom J.D. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. J. Biol. Chem. 272:1997;9197-9203.
15. Vaidya S., Bostedor P., Kurtz M.M., Bergstrom J.D., Bansal V.S. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthetasen inhibitor zaragozic acid A. Arch. Biochem. Biophys. 355:1998;84-92.
16. Westfall D., Aboushadi N., Shackelford J.E., Krisans S.K. Metabolism of farnesol: phosphorylation of farnesol by rat liver microsomal and peroxisomal fractions. Biochem. Biophys. Res. Commun. 230:1997;562-568.
17. Bentinger M., Grunber J., Peterson E., Swiezewska E., Dallner G. Phosphorylation of farnesol in rat liver microsomes: properties of farnesol kinase and farnesyl phosphate kinase. Arch. Biochem. Biophys. 353:1998;191-198.
18. Parker R.A., Pearce B.C., Clark R.W., Gordan D.A., Wright J.J.K. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 268:1993;11230-11238.
19. Pearce B.C., Parker R.A., Deason M.E., Qureshi A.A., Wright J.J.K. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35:1992;3595-3606.
20. Bradfute D.L., Simoni R.D. Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl coenzyme A reductase levels. J. Biol. Chem. 269:1994;6645-6650.
21. Shoff S.M., Grummer M., Yatvin M.B., Elson C.E. Concentration-dependent increase in murine P388 and B16 population doubling time by the acyclic monoterpene geraniol. Cancer Res. 51:1991;37-42.
22. Burke Y.D., Stark M.J., Roach S.L., Sen S.E., Crowell P.L. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids. 32:1997;151-156.
23. Miquel K., Pradines A., Favre G. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem. Biophys. Res. Commun. 225:1996;869-876.
24. He L., Mo H., Hadisusilo S., Qureshi A.A., Elson C.E. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J. Nutr. 127:1997;668-674.
25. Yu S.G., Hildebrandt L.A., Elson C.E. Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J. Nutr. 125:1995;2763-2767.
26. Kang K.S., Ryu S.H., Ahn B.Z. Antineoplastic natural products and the analogues. IV. Aurapten, the cytotoxic coumarin from Poncirus trifoliata against L1210 cells. Arch. Pharamacol. Res. (Seoul). 8:1985;187-190.
27. Komiyama K., Iizuka K., Yamaoka M., Watanabe H., Tsuchiya N., Umezawa I. Studies on the biological activity of tocotrienols. Chem. Pharm. Bull. 37:1989;1369-1371.
28. Mo H., Elson C.E. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J. Nutr. 129:1999;804-813.
29. Yaguchi M., Miyazawa K., Katagiri T., Nishimaki J., Kizaki M., Tohyama K., Toyama K. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia. 11:1997;779-787.
30. Weisz B., Giehl K., Gana-Weisz M., Egozi Y., Ben-Baruch G., Marciano D., Gierschik P., Kloog Y. A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice. Oncogene. 18:1999;2579-2588.
31. Egozi Y., Weisz B.M., Gana-Weisz G., Ben-Baruch G., Kloog Y. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist. Int. J. Cancer. 80:1999;911-918.
32. Meigs T.E., Sherwood S.W., Simoni R.D. Farnesyl acetate, a derivative of an isoprenoid of the mevalonate pathway, inhibits DNA replication in hamster and human cells. Exp. Cell Res. 219:1995;461-470.
33. Kothapalli R., Lui E.M., Guthrie N., Chambers A.F., Carroll K.K. Effects of long-chain fatty amines on the growth of ras-transformed NIH 3T3 cells. Biochem. Pharmacol. 47:1994;1909-1916.
34. Ura H., Obara T., Shudo R., Itoh A., Tanno S., Fujii T., Nishino N., Kohgo Y. Selective cytotoxicity of farnesylamine to pancreatic carcinoma cells and Ki-ras-transformed fibroblasts. Mol. Carcin. 21:1998;93-99.
35. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
36. Cotter T.G., Lennon S.V., Glynn J.G., Martin S.J. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumor and normal cells. Anticancer Res. 10:1990;1153-1160.
37. Stewart B. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J. Natl. Cancer Inst. 86:1994;1286-1296.
38. Qureshi A.A., Pearce B.C., Nor R.M., Gapor A., Peterson D.M., Elson C.E. Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J. Nutr. 126:1996;389-394.
39. Hayes K.C., Pronczuk A., Liang J.S. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters. Proc. Soc. Exp. Biol. Med. 203:1993;353-359.
40. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., Arai H., Inoue K. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 409:1997;105-108.
41. Elson C.E. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. J. Nutr. 125:1995;1666s-1672s.
42. Elson C.E., Peffley D.M., Hentosh P., Mo H. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proc. Soc. Exp. Biol. Med. 221:1999;294-311.
43. Mo H., Peffley D.M., Elson C.E. Targeting the action of isoprenoids and related phytochemicals to tumors. Heber D., Blackburn G.L., Go V.L.W. Nutritional Oncology. 1999;379-391 Academic Press, San Diego, CA.
44. Potter V.R. The biochemical approach to the cancer problem. Fed. Proc. 17:1958;691-697.
45. Siperstein M.D., Fagan V.M. Deletion of the cholesterol-negative feedback system in liver tumors. Cancer Res. 24:1964;1108-1115.